Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Multicenter Randomized Study Comparing the Effect of Adjuvant Chemotherapy for Six Months With Gemcitabine-Oxaliplatin 85 mg/m2 (GEMOX 85) to Observation in Patients Who Underwent Surgery for Cancer of the Bile Ducts

NCT01313377 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT01313377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01313377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Multicenter Randomized Study Comparing the Effect of Adjuvant Chemotherapy for Six Months With Gemcitabine-Oxaliplatin 85 mg/m2 (GEMOX 85) to Observation in Patients Who Underwent Surgery for Cancer of the Bile Ducts
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2009
Completion date
June 30, 2016
Enrollment
190 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

extrahepatic bile duct cancer, gallbladder cancer, liver cancer